Graded
The US health department published a draft policy under which it would not act against pharmacies that make BPC-157 on a prescription for a named patient, until the FDA decides by rule. It is still not an approved medicine.
PL

BPC-157

Body Protection Compound 157 · PL 14736 · pentadecapeptide BPC 157

A synthetic peptide popular for injuries. Only three studies in people exist, 30 people in total, none with a comparison group. No such medicine exists.

This site is for information and education only. It does not promote or encourage the use or purchase of the substances described and is not medical advice. Many are not authorised as medicines and their safety has not been established. We sell nothing and have no ties to sellers. For health decisions, consult a doctor.

Type
Peptide
Stage
Still being studied
Safety
Not known
Doping
Banned in sport, WADA 2026
Risk of fakes
High
Checked
Not yet

Risk of fakes. Sources: study 1.

Is it legal

How much research exists

Scientific papers
234
Studies with random groups
0
Registered studies in people
4

Scientific papers per year 2015–2025

These are search results. A count shows how much exists, not how good the studies are. 1 Nov 2026.

What studies show

  • DRecovery and injury

    Not clear. Only uncontrolled reports in people, rated very unreliable. Mostly studies in rats and mice.

What the data show

A review of studies searched to June 2026 found three studies in people, 30 people in total: a report on 16 people with knee pain, a small study of 12 people with long-term bladder inflammation, and a safety test of giving it into a vein in 2 people. All were rated poor quality and the results very uncertain [1]. None had a comparison group, so improvement cannot be separated from natural recovery or the placebo effect.

No study in people with random groups has been published. Two studies of muscle and joint injuries are registered (NCT07437547, NCT07803250), and a study from 2015 (NCT02637284) has posted no results.

In July 2026 FDA staff proposed that US pharmacies should not make BPC-157. The use reviewed was ulcerative colitis, and a law firm summary gives too little information on safety, effect and the substance itself as the reasons. FDA advisers voted 8 to 6 to allow it, with one abstention. That vote is not binding and changes nothing legally on its own.

What the animal data really mean

Most papers cover rats and mice. Of 224 papers matching our search on 1 November 2026, 172 listed the same author, so independent confirmation is limited.

Three limits matter when reading these papers:

  • The injury differs. A surgeon cutting a tendon in young, healthy rats is not the same as a long-term tendon problem in a person.
  • The way it is given differs. Animal studies often inject carefully prepared solutions into the belly.
  • Independent work is weaker. In a 2026 rat Achilles study from outside that group, BPC-157 did not reach a clear result on overall tissue scores or on the force needed to break the tendon, while TB-500 did on several measures [2].

Healing data from animals justify a study in people. They do not show that a substance works in people.

Safety

Seeing no harm in 30 people cannot establish safety. Reviews flag open concerns, including contamination, wrong contents, and possible effects of promoting blood vessel growth [3] [4]. There are no long-term data in people. Products sold online are not made to medicine standards, and injecting them adds infection risk.

What we don't know

  • Whether it does anything useful in people compared with placebo
  • Long-term safety, including any effect on existing tumours
  • Safety in pregnancy, in teenagers or alongside other medicines
  • What is actually in products sold online

Alternatives

For tendon and muscle injuries, the proven path is seeing a doctor and physiotherapy with gradually more load. See the recovery page.

When to see a doctor

See a doctor for an injury that does not improve or gets worse, or for redness, swelling or fever after any injection. Call 112 for chest pain, severe breathlessness, or signs of a severe allergic reaction. Tell your doctor about anything you have taken. Suspected side effects can be reported to the national medicines agency, in Poland URPL.

Reported side effects

What doctors, patients and companies reported to the US medicines agency (FDA), and single cases described in medical journals. A report says what happened to someone after taking the substance. It does not prove the substance caused it, and it does not say how often it happens. Reports do not change any grade.

Reports to the FDA (USA)

Reports
26
Of these, serious
21
Most often reportedReports
Shortness of breath3
Skin redness3
Headache3
Stomach discomfort2
Balance problems2
Dizziness2
Could not tolerate it2
Tiredness2

Serious means the person went to hospital, their life was in danger, they were left with lasting harm, or they died. One report can list several side effects.

FDA reports come from openFDA, cases from a PubMed search. The editors have not read these cases yet. Titles stay in the original language. As of 3 Nov 2026.

Videos on YouTube

Doctor or scientist

BPC-157 for Pain: What the Evidence Actually Says

Pain Specialists Australia | Pain Education Lab · 8 Sept 2026

Two pain medicine specialists go through the studies on BPC-157, TB-500, MOTS-c and GHK-Cu, the risk of contaminated products bought online, including heavy metals, and why a doctor should assess you first.

Doctor or scientist

BPC-157: great marketing, not great science

Peter Attia MD · 11 Aug 2026

A clip from the podcast of a doctor who works on health in older age. The title sums up the conclusion: great marketing, not great science. The full episode also covers safety and grey-market peptides.

Doctor or scientist

BPC-157: A Shoulder Surgeon's Honest Take

Patrick Denard, MD · 5 Aug 2026

An orthopaedic shoulder surgeon goes through what studies say about BPC-157 for shoulder injuries. The description advertises paid consultations and his own guide.

The description has ads

Creator

Jeff Nippard's Peptide Video: Here's What I Think

Fazlifts · 23 Oct 2026

A coach responds to the Nippard video. According to the chapters in the description, he covers GLP-1 medicines using a client as an example, then BPC-157 and TB-500, the risk of products without quality control, and why to be sceptical of the claims.

The description has ads

Creator

The Best & Worst Peptides (Ranked)

Jeff Nippard · 8 Oct 2026

A short video in which the author rates popular peptides on a scale from S to F. His ratings are an opinion on whether something is worth taking. Our grades from A to E only say how strong the studies are. The comparison below is based on the video description.

Creator

Peptides Are Insane

Jeff Nippard · 28 Sept 2026

A bodybuilder with a biochemistry degree goes through peptides for weight loss, injury healing and longevity: what works, what the risks are and where studies are missing. The description lists his sources, mostly large studies of semaglutide and tirzepatide.

The description has ads

All videos we checked

Studies we have read

StudiesKind of studyWho was studiedPeopleDurationDose as studiedWho paid
Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance.Sports Med 2026Review of studiespeople–––Unknown
Effects of BPC-157 and TB-500 on Achilles tendon healing in rats: A histopathological and biomechanical study.Joint diseases and related surgery 2026In animalsrats, Achilles tendon transection and repair324 wk–Unknown
Dangers of Injectable Peptides and Other Unregulated "Biohacking" Drugs.Mo Med 2026Review of studiespeople–––Unknown
Human evidence for BPC-157 in orthopaedic and regenerative medicine: a systematic review of efficacy and safety.Acta Orthop Belg 2026Review of studiespeople30––Unknown
Intra-Articular Injection of BPC 157 for Multiple Types of Knee Pain.Altern Ther Health Med 2021Case reportspeople16––Unknown

More papers we found

We found these papers automatically in PubMed. The editors have not read them yet, and they do not affect any grade. Titles stay in the original language.

All papers and studies we found (162)

Short answers

Does BPC-157 work?
A synthetic peptide popular for injuries. Only three studies in people exist, 30 people in total, none with a comparison group. No such medicine exists. Recovery and injury: grade D, not clear. Only uncontrolled reports in people, rated very unreliable. Mostly studies in rats and mice.
Is BPC-157 legal?
PL: No approval. Polish health inspectors warn that synthetic peptides sold as research chemicals are not medicines and selling them is illegal. EU: No approval. The European medicines database (EMA), which covers EU and national approvals, lists no such medicine (9 October 2026). US: No approval. No approved medicine. On 30 October 2026 the US health department (HHS) published a draft policy: it does not plan to act against pharmacies and doctors that make it on a prescription for a named patient, from an FDA-registered maker, until the FDA decides by rule. The draft is not binding, and comments close on 13 November 2026.
Is BPC-157 banned in sport?
Banned in sport, WADA 2026.
Is BPC-157 safe?
Not known.

Compare with TB-500Plain text for machines

Change history

  • Legal

    The US health department published a draft policy under which it would not act against pharmacies that make BPC-157 on a prescription for a named patient, until the FDA decides by rule. It is still not an approved medicine.

    bpc-157Source 1Source 2

  • Legal

    FDA staff proposed that pharmacies should not make BPC-157. FDA advisers voted 8 to 6, with one abstention, to allow it. The vote is not binding.

    bpc-157Source 1Source 2

  • Legal

    The FDA announced a review of BPC-157 and other peptides. A law firm reports that they left a US list of substances raising concerns after requests were withdrawn. This does not mean pharmacies may legally make them.

    bpc-157Source 1Source 2